News
ABT
116.79
+2.92%
3.31
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Benzinga · 53m ago
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
Benzinga · 1h ago
Here's the major earnings before the open tomorrow
Seeking Alpha · 9h ago
Pre-Market Earnings Report for January 22, 2025 : PG, JNJ, ABT, APH, TRV, TEL, HAL, TDY, TXT, ALLY, CBSH, CMA
NASDAQ · 11h ago
Abbott Laboratories set for stellar Q4 2024 earnings amid optimism for 2025
Seeking Alpha · 13h ago
Notable companies reporting before tomorrow’s open
TipRanks · 14h ago
See Which Of The Latest 13F Filers Holds Abbott Laboratories
NASDAQ · 14h ago
Top Seeking Alpha Quant picks in Technology ahead of Q4 earnings
Seeking Alpha · 15h ago
Abbott Labs Price Target Maintained With a $135.00/Share by RBC Capital
Dow Jones · 15h ago
RBC Capital Reiterates Outperform on Abbott Laboratories, Maintains $135 Price Target
Benzinga · 15h ago
DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?
NASDAQ · 16h ago
5 Dividend Aristocrats Where Analysts See Capital Gains
NASDAQ · 20h ago
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
The Motley Fool · 21h ago
5 Stocks to Watch for Earnings This Week
Barchart · 21h ago
Abbott Laboratories (ABT) Gets a Buy from RBC Capital
TipRanks · 1d ago
HAE or ABT: Which Is the Better Value Stock Right Now?
NASDAQ · 1d ago
Beckton, Dickinson: Hold, Momentum Is Gaining, Just Need More Growth
Seeking Alpha · 1d ago
Abbott Stock Ahead of Q4 Earnings Results: Smart Buy or Risky Move?
NASDAQ · 1d ago
TMDX Stock Down Despite Responding to Misleading Short-Seller Report
NASDAQ · 1d ago
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
NASDAQ · 1d ago
More
Webull provides a variety of real-time ABT stock news. You can receive the latest news about Abbott Labs through multiple platforms. This information may help you make smarter investment decisions.
About ABT
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.